(Total Views: 345)
Posted On: 05/13/2019 4:18:19 PM
Post# of 154849
My key takeaways from initial listen:
1) Noted GILD failed P2 NASH study
2) NASH study cost is $12,000 and will not impact focus on HIV or cancer
3) Hope to get NASH results back in 8 weeks, typically 4-5 months but requested this study to be expedited
4) No raises announced and they have a funding strategy/plan that will be discussed at upcoming investor meeting
1) Noted GILD failed P2 NASH study
2) NASH study cost is $12,000 and will not impact focus on HIV or cancer
3) Hope to get NASH results back in 8 weeks, typically 4-5 months but requested this study to be expedited
4) No raises announced and they have a funding strategy/plan that will be discussed at upcoming investor meeting
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
